how is glp-1 produced GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Science Behind GLP 1 GIP

Targeting cartilage breakdown by reducing catabolic enzyme activity is an important strategy for treating or modify the course of OA 55

Around two weeks after FDA approval, the oral Wegovy pill hit the market in the U.S

One of the Patriarchs of the TLBQI+ community

Research has examined investigated 5-Amino-1MQ effects on cellular respiration, mitochondrial activity, and energy expenditure markers in cultured adipocytes extending the Kraus findings on adipose energy expenditure

For example, if I have a patient who has a BMI of 42 and multiple comorbidities, I would lean towards Zepbound, since this patient would benefit from losing at least 20% of their body weight

In December 2024, the panel denied a plaintiff's motion to add (DVT) injuries , including venous thromboembolism and pulmonary embolism, to MDL 3094 cases